Mesa Laboratories Inc (MLAB)
Profitability ratios
Return on sales
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | |
|---|---|---|---|---|---|
| Gross profit margin | — | 61.64% | 61.02% | 59.18% | 64.97% |
| Operating profit margin | — | -125.85% | -13.92% | -11.05% | -3.96% |
| Pretax margin | — | -127.50% | -0.18% | 1.94% | 1.72% |
| Net profit margin | — | -117.60% | 0.42% | 1.01% | 2.44% |
Mesa Laboratories Inc's profitability ratios show a fluctuating trend over the years. The gross profit margin, which measures the company's ability to generate profit from its revenue after accounting for the cost of goods sold, decreased from 64.97% in March 2021 to 59.18% in March 2022, improved to 61.02% in March 2023, and further increased to 61.64% in March 2024.
On the other hand, the operating profit margin, which indicates the company's efficiency in managing its operating expenses in relation to revenue, declined significantly from -3.96% in March 2021 to -11.05% in March 2022, further dropping to -13.92% in March 2023, and drastically decreasing to -125.85% in March 2024, suggesting potential financial challenges.
The pretax margin, representing the company's profitability before accounting for taxes, demonstrated a mixed performance, with positive margins of 1.72% in March 2021 and 1.94% in March 2022, but turned negative at -0.18% in March 2023 and a substantial negative margin of -127.50% in March 2024.
Similarly, the net profit margin, which reflects the company's bottom line profitability after all expenses, showed varying results. It declined from 2.44% in March 2021 to 1.01% in March 2022, further dropping to 0.42% in March 2023, and significantly decreased to -117.60% in March 2024, indicating a substantial net loss.
Overall, Mesa Laboratories Inc's profitability ratios illustrate a mix of financial performance over the years, with improvements in gross profit margin but challenges in operating profit margin, pretax margin, and net profit margin, suggesting the company may be facing profitability and efficiency issues that require further analysis and attention.
Return on investment
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | — | -60.89% | -4.61% | -2.88% | -0.88% |
| Return on assets (ROA) | — | -56.90% | 0.14% | 0.26% | 0.55% |
| Return on total capital | — | -185.67% | 0.84% | 1.19% | -1.26% |
| Return on equity (ROE) | — | -174.87% | 0.24% | 0.48% | 0.81% |
Mesa Laboratories Inc's profitability ratios reflect a fluctuating performance over the past few years.
- Operating return on assets (Operating ROA): The company's operating ROA has shown a decreasing trend from -0.88% in March 2021 to -4.61% in March 2023 and a significant drop to -60.89% in March 2024. This indicates that Mesa Laboratories Inc's operating efficiency in generating profits from its assets has worsened over the period.
- Return on assets (ROA): Mesa Laboratories Inc's ROA has also varied, starting at 0.55% in March 2021, declining to 0.14% in March 2023, and plummeting to -56.90% in March 2024. This indicates a significant decrease in the company's ability to generate profits relative to its total assets.
- Return on total capital: The return on total capital has fluctuated as well, moving from -1.26% in March 2021 to 0.84% in March 2023 before sharply declining to -185.67% in March 2024. This ratio suggests that Mesa Laboratories Inc may be struggling to generate returns relative to its total capital employed in the business.
- Return on equity (ROE): Mesa Laboratories Inc's ROE has displayed a similar pattern, with a decrease from 0.81% in March 2021 to 0.24% in March 2023, followed by a substantial drop to -174.87% in March 2024. This indicates a significant decline in the company's ability to deliver returns to its equity shareholders.
Overall, the downward trends in these profitability ratios highlight challenges in Mesa Laboratories Inc's ability to efficiently utilize its assets and capital to generate sustainable profits and returns for its shareholders.